1. Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A;Pasi;N Engl J Med,2020
2. Gene therapy for hemophilia;Nathwani;Hematology Am Soc Hematol Educ Program,2019
3. Updated follow-up of the Alta study, a phase 1/2, open label, adaptive, dose-ranging study to assess the safety and tolerability of SB-525 gene therapy in adult patients with severe hemophilia A;Konkle;Blood,2019
4. First in human gene therapy study of AAVhu37 capsid vector technology in severe hemophilia A;Pipe;Blood,2019
5. Efficacy and safety in 15 hemophilia B patients treated with the AAV gene therapy vector Fidanacogene Elaparvovec and followed for at least 1 year;George;Blood,2019